Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data

Эпизоды

Advances in Thyroid Cancer Treatment
29 авг· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss emerging data and advances in thyroid cancer treatment.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Incurable HPV Negative Head and Neck Cancer
21 авг· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in incurable HPV negative head and neck cancer.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Пропущенные эпизоды?

Нажмите здесь, чтобы обновить ленту.
Recurrent/Metastatic HPV Positive Head and Neck Cancer
14 авг· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in recurrent/metastatic HPV positive head and neck cancer.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Curable HPV Negative Head and Neck Cancer
7 авг· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV negative head and neck cancer.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Curable HPV Positive Head and Neck Cancer
30 июл· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV positive head and neck cancer.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
What is a Bone Marrow Transplant?
12 июн· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Marco Ruiz explains the concept of bone marrow transplant, and how it is used in treating blood cancers.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?
10 июн· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Goodman, Phillips, Taneja, and Rajeeve discuss whether a patient's location can affect the treatments they can access and their overall prognosis.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?
5 июн· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Goodman, Phillips, Taneja, and Rajeeve discuss how to navigate treatment and Covid vaccination.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Bispecific Antibodies in Myeloma: Approvals and Clinical Trials
31 мая· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Curative Strategies for Patients with Smoldering Multiple Myeloma
23 мая· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Alankrita Taneja examines data from the CESAR trial, and discusses curative strategies for Smoldering Multiple Myeloma.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Management of Bispecific Antibodies Side Effects
17 мая· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Sridevi Rajeeve discusses possible side effects from bispecific antibodies, and how to manage them.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data
10 мая· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
3 мая· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Barriers to Biomarker Testing: Cost and Insurance
27 апр· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Barriers to Biomarker Testing: Ordering Tests
20 апр· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
The Adaura Trial: The Effect on EGFR+ Treatment
15 апр· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Biomarker Driven Therapy for NSCLC
13 апр· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Current Recommendations and Best Practices for Biomarker Testing
11 апр· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
The Importance of Biomarker Testing: What is Liquid Biopsy?
9 апр· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Biomarkers in NSCLC
9 апр· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.
- Слушать Слушать снова Продолжить Воспроизведение ...
- Слушать позже Слушать позже
Показать больше

Эпизоды

Advances in Thyroid Cancer Treatment

Incurable HPV Negative Head and Neck Cancer

Recurrent/Metastatic HPV Positive Head and Neck Cancer

Curable HPV Negative Head and Neck Cancer

Curable HPV Positive Head and Neck Cancer

What is a Bone Marrow Transplant?

Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?

Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?

Bispecific Antibodies in Myeloma: Approvals and Clinical Trials

Curative Strategies for Patients with Smoldering Multiple Myeloma

Management of Bispecific Antibodies Side Effects

Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma

Barriers to Biomarker Testing: Cost and Insurance

Barriers to Biomarker Testing: Ordering Tests

The Adaura Trial: The Effect on EGFR+ Treatment

Biomarker Driven Therapy for NSCLC

Current Recommendations and Best Practices for Biomarker Testing

The Importance of Biomarker Testing: What is Liquid Biopsy?

Biomarkers in NSCLC